AYTU BIOPHARMA, INC

For the period ended Mar 31, 2026. Filed May 13, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 13, 2026

AYTU$1.81+1.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Unaudited Consolidated Statements of Operations

(in thousands, except share and per share data)

Three Months Ended · Nine Months Ended
	March 31,		March 31,
	2026	2025	2026	2025
Net revenue	$12,411	$18,452	$41,464	$51,247
Cost of goods sold	4,812	5,646	15,055	15,670
Gross profit	7,599	12,806	26,409	35,577
Operating expenses:
Selling and marketing	5,929	5,194	17,249	16,125
General and administrative	4,973	4,109	14,967	13,683
Research and development	—	162	—	1,110
Amortization of intangible assets	761	920	1,731	2,762
Restructuring costs	—	—	—	2,101
Total operating expenses	11,663	10,385	33,947	35,781
(Loss) income from operations	(4,064)	2,421	(7,538)	(204)
Other income, net	149	36	540	718
Interest expense	(436)	(900)	(1,512)	(2,973)
Derivative warrant liabilities (loss) gain	(1,257)	2,261	(5,717)	8,157
(Loss) income from continuing operations before income tax expense	(5,608)	3,818	(14,227)	5,698
Income tax (expense) benefit	(10)	122	(10)	—
Net (loss) income from continuing operations	(5,618)	3,940	(14,237)	5,698
Net income from discontinued operations, net of tax	—	54	—	558
Net (loss) income	$(5,618)	$3,994	$(14,237)	$6,256
Basic weighted-average common shares outstanding (note 17)	10,511,583	6,134,634	9,992,577	6,111,550
Diluted weighted-average common shares outstanding (note 17)	10,511,583	8,204,453	9,992,577	8,606,013
Net (loss) income per share (note 17):
Basic - continuing operations	$(0.53)	$0.64	$(1.42)	$0.93
Diluted - continuing operations	$(0.53)	$0.20	$(1.42)	$(0.29)
Basic - discontinued operations, net of tax	$—	$0.01	$—	$0.09
Diluted - discontinued operations, net of tax	$—	$0.01	$—	$0.06
Basic - net (loss) income	$(0.53)	$0.65	$(1.42)	$1.02
Diluted - net (loss) income	$(0.53)	$0.21	$(1.42)	$(0.22)

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.